Structure-based design and analysis of MAO-B inhibitors for Parkinson’s disease: usingin silicoapproaches
✍ Scribed by Kare, Pavan; Bhat, Jyotsna; Sobhia, M. Elizabeth
- Book ID
- 118270044
- Publisher
- Springer
- Year
- 2013
- Tongue
- English
- Weight
- 715 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1381-1991
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## INTRODUCTION BACKGROUND Early attempts to enhance dopaminergic neurotransmission through inhibition of one of dopamine's major metabolizing enzyme -monoamine oxidase (MAO) -were made soon after the discovery of the striatal dopaminergic deficit and the efficacy of L-dopa. 1 However, side-effect
## Abstract Physical therapy is often prescribed in Parkinson's disease. To facilitate the uniformity and efficacy of this intervention, we analyzed current evidence and developed practice recommendations. We carried out an evidence‐based literature review. The results were supplemented with clinic